Chairwoman, AZBio Board of Directors
Vice President, Stem Cell Operations and Tucson Facility
Kristen Swingle was elected Chairwoman of the AZBio Board of Directors in January 2018.
Kristen Swingle has been responsible for overseeing all operations at CBR’s laboratory in Tucson, Arizona, since 2007.
Kristen has a strong background in process implementation, continuous improvement and leadership development. During her tenure at CBR, Kristen served as the project lead for the implementation of AXP processing at CBR and was integral in the implementation of CBR’s cord tissue product offering. In her current role, Kristen is primarily responsible for serving our clients through her oversight of our client sales and service and laboratory operations teams.
A Before coming to CBR, Kristen held the position of Microbiology Lab Manager for an environmental testing laboratory.
Kristen holds a BS in Biology from Northern Arizona University and Master of Science (MS), Medical Sciences from Texas A&M University.
About Cord Blood Registry
Cord Blood Registry® (CBR®) is the world’s largest newborn stem cell company. Founded in 1992, CBR is entrusted by parents with storing samples from more than 600,000 children. CBR is dedicated to advancing the clinical application of cord blood and cord tissue stem cells by partnering with institutions to establish FDA-regulated clinical trials for conditions that have no cure today.
CBR was recognized by AZBio in 2013 as the Arizona Bioscience Company of the Year, and is one our leading life science employers in Southern Arizona.